By Aleeza Furman | January 29, 2025
Court data shows that the Philadelphia Court of Common Pleas saw more eight-plus-figure civil jury verdicts in 2024 than it had in any single year, going back to at least 2017. And damages awards seem to be trending larger in more than just the highest-stakes cases.
By Amanda Bronstad | January 28, 2025
Objections to Johnson & Johnson's talc bankruptcy plan cite the U.S. Supreme Court's decision last year invalidating nonconsensual releases in Purdue Pharma's $6 billion opioid settlement.
By Amanda O'Brien | January 27, 2025
In a Chapter 7 filing, AkinMears indicated it was indebted to a Virage Capital Management unit for over $115 million and Rocade Capital for another $86 million.
By Aleeza Furman | January 27, 2025
Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form complaint, however the defendants are saving their challenge to certain claims for later.
By Amanda Bronstad | January 24, 2025
At least three lawsuits have been filed against the Los Angeles Department of Water & Power over the Palisades wildfire, while nearly 30 name Edison over the Eaton wildfire.
By Amanda Bronstad | January 23, 2025
The deal, announced Thursday, removes nonconsensual releases to the Sackler family, Purdue's founders, which the U.S. Supreme Court had invalidated last year.
By Edward Neiger and Alexandra Robertson and Gregory Lawrence | January 23, 2025
The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA issued a drug safety communication about long term Suboxone sublingual film use and the increased risk of serious dental problems. FDA ordered that a new warning about the risk of dental problems be added to the Suboxone prescribing information and patient medication guide. In June of 2022, a warning about the increased risk of dental problems was finally added to the prescribing information."
By Amanda O'Brien | January 22, 2025
Recruiters and observers in the market compared Kirkland’s move into Philadelphia with Goodwin Procter’s 2023 entry.
By Amanda O'Brien | January 22, 2025
Goodwin Procter, which arrived in the city early in 2023 with a focus on life sciences deals and private equity, could be an appropriate comparison. The firm added just five new lawyers locally in 2024.
By Aleeza Furman | January 22, 2025
The plaintiff filed a motion for a new trial, arguing that, “At a minimum, the verdict shows confusion and lack of understanding of the issues or instructions.”
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Our client, a boutique plaintiffs firm is seeking to hire a junior to mid-level litigation associate to join its growing team. Hired associ...
SALARY: $8,000.69 Biweekly$17,334.83 Monthly$208,017.95 AnnuallyOPENING DATE: 01/29/2025CLOSING DATE: 02/27/2025 11:59 PM PacificDEFINITION/...
Our client is seeking to hire a supervisory attorney for their growing Alabama team. Qualified candidates will have 8+ years of litigation...